Deep vein thrombosis (DVT) is the subject of hundreds of medical studies worldwide. You might seek out clinical trials because your current DVT treatment isn’t working well. If you have a family ...
An acute pulmonary embolism occurs when a blood clot blocks one or more vessels in the lung. In patients at moderate or high ...
O’Sullivan is an interventional radiologist — a physician who specializes in minimally invasive, targeted treatments. In mid-March at the Society of Interventional Radiology scientific meeting in ...
Expanding access to timely, evidence-based blood clot care in community settings Being recognized as the inaugural ...
Medically reviewed by Lauren Schlanger, MD Key Takeaways A blood clot in your arm is often associated with a health condition like cancer or the use of an inserted device like a catheter or pacemaker, ...
Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...
Deep vein thrombosis, or DVT, is a potentially life-threatening blood clotting condition. If you’ve ever had DVT or been at risk for this condition, you’ve likely been given drugs to help break up the ...
Deep vein thrombosis (DVT) is a blood clot that forms inside a vein deep in the body, whereas superficial thrombophlebitis (STP) is inflammation of the veins just below the skin’s surface. STP can ...
There are several superficial vein thrombosis treatment options. A person’s symptoms and overall health can influence the type of treatment they receive. Superficial vein thrombosis (SVT), also known ...
Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...
Global DVT Screening and Treatment Devices Market provides overview of the market segmentation, size, share, new innovations information up to that point. This market report trends may have evolved ...